| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |